Ready to play
Ready to play
The U.S. Food and Drug Administration (FDA) has approved the use of a hyaluronic acid-based injectable gel to treat horizontal neck lines and improve skin appearance in adults over 21 years old. This decision marks the first approval of an injectable treatment specifically designed for this area, with a reported improvement rate of up to 74.8% after one month, and sustained results lasting six months in 66% of cases. The product, called "Skinvive by Juvéderm," is used to enhance skin hydration and texture, and contains lidocaine to reduce pain during the procedure.
Notice: This Is an AI-Generated Summary
Comments (0)